{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:52:14Z","timestamp":1770238334626,"version":"3.49.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Results from investigations in one area of the world may not translate to another if patient characteristics and practices differ. We examine differences in the presentation and management of emergency department (ED) patients with dyspnoea from acute heart failure syndromes (AHFS) between the USA, Western Europe, and Eastern Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The URGENT Dyspnoea study was a multinational prospective observational study of dyspnoeic ED patients with AHFS from 18 countries. Acute heart failure syndrome patients from the USA and Western and Eastern Europe underwent dyspnoea assessments within 1 h of the first physician evaluation. Patient characteristics, evaluation, and treatments were compared between geographical regions using analysis of variance and \u03c72 tests. Four hundred and ninety-three patients with AHFS met the inclusion criteria. Participants in the USA were more frequently non-white, younger, on chronic beta-blocker therapy, and with an ejection fraction \u226440% when compared with Eastern and Western Europe. Patients from Eastern Europe were more likely to present with de novo heart failure and have ischaemic electrocardiogram changes. Pulmonary oedema was more common on chest radiograph in Western Europe, but natriuretic peptide levels were elevated in all three regions. Diuretic use was similar across all the regions. Intravenous nitroglycerin was used more frequently in Eastern (32.8%) and Western Europe (24.4%) compared with the USA (2.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>International differences in AHFS presentations and management between regions suggest results from clinical trials in one region may not translate directly to another. These differences should be considered when designing trials and interpreting the results from clinical investigations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfq133","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T20:30:03Z","timestamp":1282854603000},"page":"1253-1260","source":"Crossref","is-referenced-by-count":53,"title":["International Variations in the Clinical, Diagnostic, and Treatment Characteristics of Emergency Department Patients with Acute Heart Failure Syndromes"],"prefix":"10.1093","volume":"12","author":[{"given":"Sean P.","family":"Collins","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, University of Cincinnati , Cincinnati, OH ,","place":["USA"]}]},{"given":"Peter S.","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Northwestern University , Chicago, IL ,","place":["USA"]}]},{"given":"Christopher J.","family":"Lindsell","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Cincinnati , Cincinnati, OH ,","place":["USA"]}]},{"given":"Demetrios N.","family":"Kyriacou","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Northwestern University , Chicago, IL ,","place":["USA"]}]},{"given":"Alan B.","family":"Storrow","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Vanderbilt University , Nashville, TN ,","place":["USA"]}]},{"given":"Judd E.","family":"Hollander","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Pennsylvania , Philadelphia, PA ,","place":["USA"]}]},{"given":"J.","family":"Douglas Kirk","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of California-Davis , Sacramento, CA ,","place":["USA"]}]},{"given":"Chadwick D.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Wake Forest University , Winston Salem, NC ,","place":["USA"]}]},{"given":"Richard","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Henry Ford Hospital , Detroit, MI ,","place":["USA"]}]},{"given":"W.","family":"Frank Peacock","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Cleveland Clinic , Cleveland, OH ,","place":["USA"]}]},{"given":"Miguel","family":"Tavares","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care, Hospital Geral de Santo Ant\u00f3nio , Porto ,","place":["Portugal"]}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine Hopital Lariboisiere, Universit\u00e9 Paris Diderot , U942 Inserm, Paris ,","place":["France"]}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Northwestern University , Chicago, IL ,","place":["USA"]}]}],"member":"286","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"key":"2026020203343611800_ejhfhfq133-bib-0001","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","article-title":"Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program","volume":"52","author":"Blair","year":"2008","journal-title":"J Am CollCardiol"},{"key":"2026020203343611800_ejhfhfq133-bib-0002","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0003","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026020203343611800_ejhfhfq133-bib-0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The EuroHeart Failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0006","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials","volume":"298","author":"McMurray","year":"2007","journal-title":"J Am Med Assoc"},{"key":"2026020203343611800_ejhfhfq133-bib-0007","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"J Am Med Assoc"},{"key":"2026020203343611800_ejhfhfq133-bib-0008","first-page":"1531","volume":"287","author":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","year":"2002","journal-title":"J Am Med Assoc"},{"key":"2026020203343611800_ejhfhfq133-bib-0009","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MJT.0b013e31816b436e","article-title":"Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study","volume":"15","author":"Pang","year":"2008","journal-title":"Am J Ther"},{"key":"2026020203343611800_ejhfhfq133-bib-0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurheartj\/ehp458","article-title":"The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study","volume":"31","author":"Mebazaa","year":"2010","journal-title":"Eur Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0011","article-title":"Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial","author":"Pitt","year":"2009","journal-title":"Int J Cardiol"},{"key":"2026020203343611800_ejhfhfq133-bib-0012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ahj.2009.07.003","article-title":"The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction","volume":"158","author":"Gheorghiade","year":"2009","journal-title":"Am Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0013","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ahj.2007.03.012","article-title":"Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0014","first-page":"172","article-title":"NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland","volume":"94","author":"Nicol","year":"2008","journal-title":"Heart (British Cardiac Society)"},{"key":"2026020203343611800_ejhfhfq133-bib-0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/eurjhf\/hfq021","article-title":"Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study","volume":"12","author":"Metra","journal-title":"Eur J Heart Fail"},{"key":"2026020203343611800_ejhfhfq133-bib-0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","article-title":"Fluid overload in acute heart failure\u2013re-distribution and other mechanisms beyond fluid accumulation","volume":"10","author":"Cotter","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026020203343611800_ejhfhfq133-bib-0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"2026020203343611800_ejhfhfq133-bib-0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2006.02.038","article-title":"The pathophysiology of acute heart failure\u2013is it all about fluid accumulation?","volume":"155","author":"Cotter","year":"2008","journal-title":"Am Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0019","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","article-title":"Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis","volume":"50","author":"Levy","year":"2007","journal-title":"Ann Emerg Med"},{"key":"2026020203343611800_ejhfhfq133-bib-0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejheart.2008.01.002","article-title":"Overview of emerging pharmacologic agents for acute heart failure syndromes","volume":"10","author":"De Luca","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026020203343611800_ejhfhfq133-bib-0021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehn048","article-title":"A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach","volume":"29","author":"Pang","year":"2008","journal-title":"Eur Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0022","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ahj.2007.03.012","article-title":"Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"2026020203343611800_ejhfhfq133-bib-0023","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.annemergmed.2008.12.029","article-title":"S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea","volume":"53","author":"Collins","year":"2009","journal-title":"Ann Emerg Med"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfq133","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/12\/11\/1253\/66522505\/eurjhf_12_11_1253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/12\/11\/1253\/66522505\/eurjhf_12_11_1253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:34:43Z","timestamp":1770021283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/12\/11\/1253\/8435893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,1]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,1,13]]},"published-print":{"date-parts":[[2010,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfq133","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,11]]},"published":{"date-parts":[[2010,11,1]]}}}